MANINI, MATTEO ANGELO
 Distribuzione geografica
Continente #
EU - Europa 2.172
NA - Nord America 1.789
AS - Asia 1.452
Continente sconosciuto - Info sul continente non disponibili 228
SA - Sud America 115
AF - Africa 30
OC - Oceania 7
Totale 5.793
Nazione #
US - Stati Uniti d'America 1.708
GB - Regno Unito 972
CN - Cina 444
SG - Singapore 338
IT - Italia 289
DE - Germania 270
BD - Bangladesh 179
SE - Svezia 162
HK - Hong Kong 144
VN - Vietnam 126
RU - Federazione Russa 112
FR - Francia 87
BR - Brasile 77
IN - India 68
CA - Canada 64
UA - Ucraina 64
IE - Irlanda 44
NL - Olanda 40
FI - Finlandia 39
KR - Corea 38
TR - Turchia 35
EU - Europa 23
DK - Danimarca 21
ID - Indonesia 20
CO - Colombia 17
CI - Costa d'Avorio 16
JP - Giappone 15
BE - Belgio 12
AR - Argentina 10
GR - Grecia 10
ES - Italia 9
MX - Messico 8
UZ - Uzbekistan 8
AU - Australia 7
CH - Svizzera 7
PL - Polonia 7
RO - Romania 7
IQ - Iraq 6
AT - Austria 5
PK - Pakistan 5
CL - Cile 4
PH - Filippine 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
MA - Marocco 3
SA - Arabia Saudita 3
SI - Slovenia 3
CR - Costa Rica 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
TH - Thailandia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 5.588
Città #
Southend 921
Ashburn 180
Singapore 180
Dallas 165
Chandler 144
Hong Kong 130
Beijing 110
Frankfurt am Main 91
San Jose 78
Milan 69
Seattle 62
New York 61
Santa Clara 57
Council Bluffs 55
Princeton 51
Ann Arbor 49
Wilmington 46
Dublin 44
Jacksonville 43
Dearborn 40
Los Angeles 34
Fairfield 32
Hanoi 32
Ho Chi Minh City 31
Buffalo 30
Toronto 30
Houston 28
Grafing 27
Nanjing 27
Moscow 25
Shanghai 25
Bengaluru 23
Lauterbourg 23
Woodbridge 23
Des Moines 22
Boardman 21
Redmond 21
Helsinki 20
Mountain View 19
Rome 19
Guangzhou 18
Serra 17
Abidjan 16
Columbus 15
Bogotá 14
Munich 14
Andover 13
Redwood City 13
Brussels 12
Cambridge 12
Phoenix 12
Saint Petersburg 11
Sakarya 11
Da Nang 9
Hefei 9
Tokyo 9
Turin 9
Hangzhou 8
Jakarta 8
Naples 8
Somerville 8
Atlanta 7
Berlin 7
Bitonto 7
Fuzhou 7
Haiphong 7
Jersey City 7
Nanchang 7
Quanzhou 7
Changsha 6
Hebei 6
Jinan 6
São Paulo 6
Athens 5
Cangzhou 5
Central District 5
Chicago 5
Dong Ket 5
Istanbul 5
Jiaxing 5
Kunming 5
London 5
Montreal 5
Mumbai 5
Ottawa 5
San Diego 5
Wuhan 5
Bari 4
Bologna 4
Brooklyn 4
Palermo 4
Piscataway 4
Rimini 4
Shenyang 4
Shenzhen 4
Sunnyvale 4
The Dalles 4
Warsaw 4
Auburn Hills 3
Baghdad 3
Totale 3.534
Nome #
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 635
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation 389
Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men 290
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 273
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis 256
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 253
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey 249
TACE with drug-eluting beads is effective for the maintenance of the milan-in status in patients with a small hepatocellular carcinoma 247
Recist versus easl criteria for the evaluation of HCC response to sorafenib 227
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 225
Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale 219
The impact of infection by multidrug resistant agents in patients with cirrhosis : A multicenter prospective study 214
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 213
Characterisation of liver nodules in patients with chronic liver disease by MRI: comparison between the LI-RADS v2014 and the Likert scale 207
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis 199
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 193
Chemoembolization with epirubicin drug eluting beads to treat early and intermediate hepatocellular carcinoma 188
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 177
The natural history of hepatic macroregenerative nodules developing in cirrhotic patients during surveillance with ultrasound (US) 175
The natural history of macroregenerative nodules prospectively detected in cirrhotic patients under surveillance 168
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 165
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients : a 5-year follow-up study after hepatitis B immunoglobulin withdrawal 164
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 158
Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients 158
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 151
Totale 5.793
Categoria #
all - tutte 14.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022349 0 23 13 39 17 10 23 41 47 55 13 68
2022/2023455 57 62 44 42 46 99 6 26 49 2 18 4
2023/2024322 14 21 21 11 95 9 25 35 18 12 34 27
2024/2025659 32 80 14 69 27 23 17 79 34 78 55 151
2025/20261.570 148 83 206 93 136 81 199 60 99 94 203 168
2026/2027192 116 76 0 0 0 0 0 0 0 0 0 0
Totale 5.793